Condition (MeSH)
Hypertensive Encephalopathy
ClinicalTrials.gov lists 7 trials for Hypertensive Encephalopathy or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
4 sections measured, none recorded · 1 not measured yet · 1 not computed
When did Hypertensive Encephalopathy trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 4 |
| 2020 | 1 |
| 2018 | 1 |
| 2016 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hypertensive Encephalopathy trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 7 |
How many Hypertensive Encephalopathy trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 4 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Hypertensive Encephalopathy? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Management of hypertensive crisis: British and Irish Hypertension Society Position document. | Journal of human hypertension | 2023 | Yes |
| Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. | Journal of clinical hypertension (Greenwich, Conn.) | 2010 | Yes |
| Reversible posterior leukoencephalopathy syndrome and bevacizumab. | The New England journal of medicine | 2006 | Yes |
| Reversible posterior leukoencephalopathy syndrome and bevacizumab. | The New England journal of medicine | 2006 | Yes |
| Seizures after carotid endarterectomy: hyperperfusion, dysautoregulation or hypertensive encephalopathy? | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery | 2003 | Yes |
Showing 5 of 6 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.